clinical & molecular determinants outcome for nonoptic pathway gliomas in adults w/neurofibromatos
Published 2 years ago • 139 plays • Length 16:27Download video MP4
Download video MP3
Similar videos
-
51:08
optic gliomas in nf1
-
2:50
optic glioma consortium
-
6:03
ask kate: nf1 optic pathway gliomas
-
17:25
promising clinical trials for glioblastoma - nicholas butowski, m.d.
-
53:38
optic pathway gliomas
-
51:51
nf summit 2022: ophthalmologic manifestations of nf1 in children
-
15:30
ophthalmic findings in nf1
-
2:05
clinical trials for neurofibromatosis
-
23:23
impact of molecular understandings, clinical trials - dr packer
-
24:31
an update on the diagnosis and management of optic gliomas
-
2:01
neurofibromatosis type 1, pheochromocytoma & optic gliomas - clinical presentation
-
1:00
dr. ferris on pembrolizumab and nivolumab in head and neck cancer
-
53:47
experimental therapies & agents in clinical trials for gliomas: ucla brain tumor virtual conference
-
57:47
aanp teaching rounds - january 25, 2021 - neoplastic disease: diagnostic approach to diffuse glioma
-
30:43
future therapies for glioblastoma multiforme by alfredo quiñones-hinojosa, md | full lecture
-
1:41
current clinical trials for neuromyelitis optica
-
45:12
novel treatments and clinical trials for low grade gliomas
-
20:06
glioblastoma and other primary brain malignancies in adults
-
22:53
focus on haematological neoplasm: me and my myeloma